Compare NWFL & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NWFL | ORGO |
|---|---|---|
| Founded | 1870 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 336.1M | 299.8M |
| IPO Year | 1996 | 2016 |
| Metric | NWFL | ORGO |
|---|---|---|
| Price | $31.31 | $2.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $33.00 | $8.50 |
| AVG Volume (30 Days) | 13.0K | ★ 937.0K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | ★ 15150.00 | 1600.00 |
| EPS | ★ 0.35 | N/A |
| Revenue | $7,999,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $34.35 | N/A |
| Revenue Next Year | $5.55 | $26.27 |
| P/E Ratio | $88.29 | ★ N/A |
| Revenue Growth | 8.11 | ★ 17.04 |
| 52 Week Low | $23.70 | $2.04 |
| 52 Week High | $32.23 | $7.08 |
| Indicator | NWFL | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 59.97 | 51.37 |
| Support Level | $27.56 | $2.20 |
| Resistance Level | $32.20 | $2.67 |
| Average True Range (ATR) | 0.72 | 0.14 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 88.04 | 62.12 |
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.